000 01550 a2200433 4500
005 20250513144330.0
264 0 _c19980817
008 199808s 0 0 eng d
022 _a0091-3057
024 7 _a10.1016/s0091-3057(98)00017-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBriggs, S L
245 0 0 _aKappa antinociceptive activity of spiradoline in the cold-water tail-flick assay in rats.
_h[electronic resource]
260 _bPharmacology, biochemistry, and behavior
_cJun 1998
300 _a467-72 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnalgesics
_xantagonists & inhibitors
650 0 4 _aAnalgesics, Opioid
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aCold Temperature
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Tolerance
650 0 4 _aFentanyl
_xpharmacology
650 0 4 _aMale
650 0 4 _aMethadone
_xpharmacology
650 0 4 _aNaloxone
_xpharmacology
650 0 4 _aNarcotic Antagonists
_xpharmacology
650 0 4 _aPain Measurement
_xdrug effects
650 0 4 _aPyrrolidines
_xantagonists & inhibitors
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReaction Time
_xdrug effects
650 0 4 _aReceptors, Opioid, kappa
_xantagonists & inhibitors
650 0 4 _aStereoisomerism
700 1 _aRech, R H
700 1 _aSawyer, D C
773 0 _tPharmacology, biochemistry, and behavior
_gvol. 60
_gno. 2
_gp. 467-72
856 4 0 _uhttps://doi.org/10.1016/s0091-3057(98)00017-3
_zAvailable from publisher's website
999 _c9598560
_d9598560